Orthocell (ASX:OCC) Total Liabilities : A$20.40 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Orthocell Total Liabilities?

Orthocell's Total Liabilities for the quarter that ended in Dec. 2024 was A$20.40 Mil.

Orthocell's quarterly Total Liabilities declined from Dec. 2023 (A$22.74 Mil) to Jun. 2024 (A$22.08 Mil) and declined from Jun. 2024 (A$22.08 Mil) to Dec. 2024 (A$20.40 Mil).

Orthocell's annual Total Liabilities declined from Jun. 2022 (A$27.99 Mil) to Jun. 2023 (A$23.46 Mil) and declined from Jun. 2023 (A$23.46 Mil) to Jun. 2024 (A$22.08 Mil).

Orthocell Total Liabilities Historical Data

The historical data trend for Orthocell's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthocell Total Liabilities Chart

Orthocell Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

2.27

2.46

27.99

23.46

22.08

Orthocell Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial															24.40	23.46	22.74	22.08	20.40

Orthocell Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Orthocell's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.306	+	(0.541	+	-4.413136522885E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	16.071	+	0.165	+	0)
	=	22.08

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	26.615	-	4.533
	=	22.08

Orthocell's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.853	+	(0.493	+	15.055
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	20.40

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	40.04	-	19.639
	=	20.40

Orthocell Total Liabilities Related Terms

Thank you for viewing the detailed overview of Orthocell's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Orthocell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150

Website

https://www.orthocell.com.au

Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir which is a collagen wrap used in peripheral nerve repair; and OrthoACI an implantation used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline such as Tendon Cell Therapy and Collagen Medical Device Platform.